IHC logo

Inspiration Healthcare Group plc Stock Price

AIM:IHC Community·UK£16.6m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

IHC Share Price Performance

UK£0.18
-0.03 (-13.95%)
UK£0.24
Fair Value
UK£0.18
-0.03 (-13.95%)
22.9% undervalued intrinsic discount
UK£0.24
Fair Value
Price UK£0.18
AnalystLowTarget UK£0.24
AnalystHighTarget UK£0.82
AnalystConsensusTarget UK£0.56

IHC Community Narratives

·
Fair Value UK£0.24 22.9% undervalued intrinsic discount

US Market Delays And Execution Risks Will Test Long Term Potential

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value UK£0.82 77.4% undervalued intrinsic discount

Bullish View That New Neonatal Market Entry Will Transform Long Term Prospects

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value UK£0.56 67.0% undervalued intrinsic discount

Neonatal Ventilation Shift And Recurring Consumables Will Support Long-Term Earnings Quality

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Trending Discussion

No trending discussion available.

Updated Narratives

IHC logo

IHC: Future Revenue Hit From Distribution Transfer Will Be Offset By Debt Reduction

Fair Value: UK£0.24 22.9% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
IHC logo

Bullish View That New Neonatal Market Entry Will Transform Long Term Prospects

Fair Value: UK£0.82 77.4% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
IHC logo

Neonatal Ventilation Shift And Recurring Consumables Will Support Long-Term Earnings Quality

Fair Value: UK£0.56 67.0% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks
0 Rewards

Inspiration Healthcare Group plc Key Details

UK£47.5m

Revenue

UK£26.8m

Cost of Revenue

UK£20.8m

Gross Profit

UK£21.8m

Other Expenses

-UK£1.0m

Earnings

Last Reported Earnings
Jan 31, 2026
Next Reporting Earnings
n/a
-0.012
43.66%
-2.19%
40.1%
View Full Analysis

About IHC

Founded
1998
Employees
214
CEO
Harout Stepanian
WebsiteView website
inspirationhealthcaregroup.com

Inspiration Healthcare Group plc designs, manufactures, and sells medical technology products worldwide. The company offers products for acute care comprising developmental and intensive care, monitoring, neonatal, obstetrics, operating theatres, pain management and developmental, respiratory, resus, thermo regulatory, and transport areas. It also offers infusion therapies and products, such as ambulatory infusion pumps, administration sets, accessories, patient infusion management systems, and medical infusion devices for acute pain management, obstetrics, parenteral nutrition, palliative care, oncology, immunoglobulin therapy, antibiotic infusion, and other, as well as manufactures and sells pneumatic ventilators. The company serves the hospital sector. Inspiration Healthcare Group plc was incorporated in 1998 and is based in Croydon, the United Kingdom.

Recent IHC News & Updates

Narrative Update Jun 26

IHC: Future Revenue Hit From Distribution Transfer Will Be Offset By Debt Reduction

Analysts have reduced their fair value estimate for Inspiration Healthcare Group from £0.30 to £0.24, citing a sharper expected revenue decline, a slightly higher projected profit margin, and a lower future P/E multiple. What’s in the News for Inspiration Healthcare Group Inspiration Healthcare Group entered into a framework agreement on 1 June 2026 with Micrel Medical Devices SA for the transfer of distribution of Micrel's infusion products in the UK to an entity controlled by Micrel, effective from 31 January 2027, according to company announcements.

Recent updates

No updates